Rare condition

Charcot-Marie-Tooth disease type 4C

2

studies recruiting now

as of 7 Sept 2026

2

studies registered in total

as of 7 Sept 2026

5

countries with a recruiting site

as of 7 Sept 2026

15 Jun 2023

most recent study posted

among recruiting studies

Recruiting trials

Showing the 2 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

Search all Charcot-Marie-Tooth disease type 4C studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

Keep watching

Get an email when a new Charcot-Marie-Tooth disease type 4C study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About Charcot-Marie-Tooth disease type 4C

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (SH3TC2).

Treatments being studied

8 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Phase 3Sorbitol (Sorbitol component of -mannitol)
Phase 3Baclofen (Baclofen)
Phase 3Naltrexone Hydrochloride (Adepend)
Phase 2Efmitermant Alfa
Phase 2Epalrestat
Phase 2Mexiletine
Phase 1/2Ubidecarenone
Phase 1/2Donaperminogene Seltoplasmid

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).